Analyst Ratings for Stemline Therapeutics (STML)

STML Rating Summary

  |   Expand Research on STML
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/5/2020 H.C. Wainwright Raghuram Selvaraju Downgrade Neutral
(Buy)		 12.50
(N/A)		 12.11
(11.83)		 -2.31% Details
5/5/2020 Ladenburg Thalmann N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 12.11
(11.83)		 -2.31% Details